ATE489937T1 - Zusammensetzungen und deren verwendung zum abfangen und inaktivieren pathogener mikroben und spermatozoen - Google Patents

Zusammensetzungen und deren verwendung zum abfangen und inaktivieren pathogener mikroben und spermatozoen

Info

Publication number
ATE489937T1
ATE489937T1 AT01916401T AT01916401T ATE489937T1 AT E489937 T1 ATE489937 T1 AT E489937T1 AT 01916401 T AT01916401 T AT 01916401T AT 01916401 T AT01916401 T AT 01916401T AT E489937 T1 ATE489937 T1 AT E489937T1
Authority
AT
Austria
Prior art keywords
composition
compositions
risk
antimicrobial
contraceptive
Prior art date
Application number
AT01916401T
Other languages
English (en)
Inventor
Sanjay Garg
Lourens Zaneveld
Robert Anderson
Donald Waller
Original Assignee
Rush Presbyterian St Luke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rush Presbyterian St Luke filed Critical Rush Presbyterian St Luke
Application granted granted Critical
Publication of ATE489937T1 publication Critical patent/ATE489937T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01916401T 2000-03-07 2001-03-06 Zusammensetzungen und deren verwendung zum abfangen und inaktivieren pathogener mikroben und spermatozoen ATE489937T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18757400P 2000-03-07 2000-03-07
PCT/US2001/007042 WO2001066084A2 (en) 2000-03-07 2001-03-06 Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa

Publications (1)

Publication Number Publication Date
ATE489937T1 true ATE489937T1 (de) 2010-12-15

Family

ID=22689528

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01916401T ATE489937T1 (de) 2000-03-07 2001-03-06 Zusammensetzungen und deren verwendung zum abfangen und inaktivieren pathogener mikroben und spermatozoen

Country Status (14)

Country Link
US (1) US6706276B2 (de)
EP (1) EP1263411B1 (de)
CN (1) CN100488517C (de)
AT (1) ATE489937T1 (de)
AU (2) AU2001243431B2 (de)
BR (1) BRPI0109078B8 (de)
CA (1) CA2402589C (de)
DE (1) DE60143566D1 (de)
ES (1) ES2357474T3 (de)
HU (1) HU230315B1 (de)
IL (2) IL151649A0 (de)
PL (1) PL202918B1 (de)
RU (1) RU2274442C2 (de)
WO (1) WO2001066084A2 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105177B1 (en) * 2000-10-20 2006-09-12 Miller Brewing Company Antimicrobial diapers and wet wipes
KR20040028336A (ko) * 2002-09-30 2004-04-03 김종국 신규한 질내 투여용 항균 온도감응성 겔 조성물
WO2004035022A2 (en) * 2002-10-15 2004-04-29 Microtherapeutics, Inc. Prepolymeric materials for site specific delivery to the body
WO2005007150A2 (en) * 2003-07-17 2005-01-27 Bar-Ilan University Method for inhibiting protein synthesis in sperm
US20050209247A1 (en) * 2003-11-07 2005-09-22 Chiron Corporation Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
US20060106117A1 (en) * 2004-11-12 2006-05-18 Kimberly-Clark Worldwide, Inc. Compound and method for prevention and/or treatment of vaginal infections
US7619008B2 (en) 2004-11-12 2009-11-17 Kimberly-Clark Worldwide, Inc. Xylitol for treatment of vaginal infections
US20060127459A1 (en) * 2004-12-15 2006-06-15 Lei Huang Urogenital infection inhibition
US20060147502A1 (en) * 2004-12-30 2006-07-06 Kimberly-Clark Worldwide, Inc. Methods for controlling microbial pathogens on currency and mail
KR100679924B1 (ko) 2005-02-28 2007-02-08 영남대학교 산학협력단 신규한 클로트리마졸 질 좌제 조성물
US8703198B2 (en) * 2005-03-02 2014-04-22 Aquatrove Biosciences Water-based personal moisturizers and lubricants, in particular vaginal lubricants, and uses thereof
US20060223765A1 (en) * 2005-03-30 2006-10-05 Kimberly-Clark Worldwide, Inc. Method for inhibiting and/or treating vaginal infection
CN101175503B (zh) * 2005-04-27 2012-12-12 深圳福诺生物技术有限公司 一种调节并保持阴道菌群和阴道酸度正常的组合物与方法
EP1885187B1 (de) 2005-05-13 2013-09-25 Novartis AG Verfahren zur behandlung von arzneimittelresistentem krebs
US7786176B2 (en) 2005-07-29 2010-08-31 Kimberly-Clark Worldwide, Inc. Vaginal treatment composition containing xylitol
GB2430881B (en) 2005-10-06 2010-10-13 Ntnu Technology Transfer As Oligoelectrolyte polyols for the treatment of mucosal hyperviscosity
US8666445B2 (en) * 2005-10-25 2014-03-04 Kyocera Corporation Apparatus, system, and method for transmission antenna switching in a portable communication device
NZ567550A (en) * 2005-11-29 2011-08-26 Novartis Ag Formulations of lactic acid salts of 4-amino-5-fluoro-3-[6-(4-methyl-piperazin-1-yl)-1 H-benzimidazol-2-yl]1H-quinolin-2-one
US7745158B2 (en) * 2005-12-14 2010-06-29 Kimberly-Clark Worldwide, Inc. Detection of secreted aspartyl proteases from Candida species
RU2329790C1 (ru) * 2006-12-07 2008-07-27 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Лечебно-профилактическое средство, обладающее антибактериальным и спермицидным действием
CN100463675C (zh) * 2007-01-29 2009-02-25 高章圈 一种可溶性缓释外用避孕药
GB0707096D0 (en) 2007-04-12 2007-05-23 Ntnu Technology Transfer As Method
AU2008256689A1 (en) * 2007-05-24 2008-12-04 New York Blood Center Inc. Rapidly dispersible vaginal tablet that provides a bioadhesive gel
RU2353395C2 (ru) * 2007-06-14 2009-04-27 Елена Борисовна Иванова Биоцидная композиция на липосомальной основе
KR101690631B1 (ko) 2007-11-27 2017-01-09 알지파마 아이피알 에이에스 바이오필름 퇴치에 있어서의 알기네이트 올리고머의 용도
DE102008005498A1 (de) * 2008-01-22 2009-07-23 Ma, Te-Lun Haftende, Spermien blockierende Wirkstoffkombination mit kontrazeptiver Wirkung
US20090197946A1 (en) * 2008-01-31 2009-08-06 Joseph Di Bartolomeo Composition and method for treatment of inflamation and infections of the genitalia, contraceptive and the prophylaxis of sexually transmitted diseases
CN101249084B (zh) * 2008-03-18 2011-09-21 上海麟翔生物技术有限公司 可预防性传播疾病的消毒组方
GB0904941D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
GB0904942D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
US8795717B2 (en) 2009-11-20 2014-08-05 Kimberly-Clark Worldwide, Inc. Tissue products including a temperature change composition containing phase change components within a non-interfering molecular scaffold
BRPI1011248A2 (pt) 2009-06-03 2016-03-22 Algipharma As métodos in vitro ou ex vivo de superação de resitência a pelo menos um antibiótico, para combate de contaminação de um sítio e melhora da eficácia de um antibiótico de macrolídeo para inibir o crescimento de bactéria mdr gram negativa, uso de um oligômero de alginato e produto
US9181465B2 (en) * 2009-11-20 2015-11-10 Kimberly-Clark Worldwide, Inc. Temperature change compositions and tissue products providing a cooling sensation
US8480852B2 (en) 2009-11-20 2013-07-09 Kimberly-Clark Worldwide, Inc. Cooling substrates with hydrophilic containment layer and method of making
US9539077B1 (en) 2011-12-05 2017-01-10 Daniel A. Dopps Method for alternatively resisting and permitting menstrual flow
CN110693812A (zh) * 2012-06-13 2020-01-17 伊沃菲姆股份有限公司 用于增强避孕杀微生物剂有效性的组合物和方法
CN102784416B (zh) * 2012-08-28 2014-04-02 福州乾正药业有限公司 一种助分娩凝胶
CN104434890A (zh) * 2013-09-24 2015-03-25 上海市计划生育科学研究所 扁桃酸的用途
CN103655457A (zh) * 2013-09-24 2014-03-26 杨莉 用于调节女性阴道pH值的温敏凝胶及其制备方法
WO2015070072A1 (en) * 2013-11-07 2015-05-14 Evofem, Inc. Methods for manufacturing contraceptive microbicides with antiviral properties
AU2014368971B2 (en) 2013-12-19 2020-02-06 Evofem, Inc. Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound
CN105250280B (zh) 2014-07-14 2020-03-10 诺维科国际控股股份有限公司 包含辛苯聚醇和喹诺里西啶生物碱化合物或其来源的杀微生物组合物
CN110225750A (zh) * 2016-10-04 2019-09-10 伊沃菲姆股份有限公司 细菌性阴道病的治疗和预防方法
US11252960B2 (en) 2017-01-31 2022-02-22 Kimberly-Clark Worldwide, Inc. Antibacterial composition including benzoic acid ester and methods of inhibiting bacterial growth utilizing the same
CN110770138A (zh) * 2017-04-24 2020-02-07 乔舒亚·D·莱文 触变性宾厄姆塑性流体避孕方法
IL258017B (en) 2018-03-11 2019-10-31 Aquafit Intimate Ltd Intravaginal device and uses thereof
CN108451895A (zh) * 2018-04-26 2018-08-28 霍尔果斯汉智医药科技有限公司 一种左炔诺孕酮阴道膨胀栓及其制备方法
WO2020076805A1 (en) * 2018-10-09 2020-04-16 Crapaud Bio, Inc. METHODS OF MAKING AND USING pH MODULATING COMPOSITIONS IN THE REPRODUCTIVE SYSTEM
EP3902399A1 (de) 2018-12-27 2021-11-03 3M Innovative Properties Company Antimikrobielle zusammensetzungen mit 1,2-alkandiolen
CN109745300B (zh) * 2019-02-02 2023-01-03 沈阳得康医药科技有限公司 不含杀精剂的物理避孕凝胶成膜剂
RU2730021C1 (ru) * 2019-10-08 2020-08-14 Общество с ограниченной ответственностью "Научно-производственная фирма ВЕРТА" Средство местного применения для лечения инфекционных вагинитов
DE102020101110A1 (de) 2020-01-17 2021-07-22 Beuth Hochschule Für Technik Berlin Antimykotische Aktivitäten von Hydrogelen auf Basis von Polysacchariden
EP4084798A1 (de) * 2020-02-21 2022-11-09 Yourchoice Therapeutics, Inc. Niclosamid-formulierungen zur verwendung als kontrazeptivum
WO2023015186A1 (en) 2021-08-03 2023-02-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Hiv-1 vaccination and samt-247 microbicide to prevent hiv-1 infection
WO2023220645A1 (en) 2022-05-10 2023-11-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Vaccine for human t-lymphotropic virus-1
US12570838B2 (en) 2022-08-23 2026-03-10 Impact Biolife Science, Inc. Antimicrobial plastic
WO2026011214A1 (en) * 2024-07-08 2026-01-15 Liquim Limited Natural-origin bioadhesive, biodegradable, protective microfilm barrier composition and method of use
CN118845630B (zh) * 2024-07-12 2025-08-22 陕西科技大学 一种卡波姆葡萄糖酸铜复合物水凝胶及其制备方法及应用

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005220A (en) 1973-02-20 1977-01-25 Laboratorios Del Dr. Esteve, S.A. Hemostatic compositions comprising salts of substituted hydroquinone sulfonic acid
DE3603444A1 (de) * 1986-02-05 1987-08-06 Thomae Gmbh Dr K Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha
IT1213323B (it) * 1986-08-07 1989-12-20 Crinos Industria Farmaco Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida
US5536743A (en) * 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
NO178843C (no) * 1988-07-11 1996-06-19 Sspl Sa Safe Sex Prod Licens Fremgangsmåte for fremstilling av et farmasöytisk preparat for å forhindre seksuelt overförbare sykdommer
US4999342A (en) * 1988-08-16 1991-03-12 Ortho Pharmaceutical Corporation Long lasting contraceptive suppository composition and methods of use
US5545673A (en) 1989-06-06 1996-08-13 Kelly; Patrick D. Method for reducing risk of infection by sexually transmitted viruses
US5624675A (en) 1989-06-06 1997-04-29 Kelly; Patrick D. Genital lubricants containing zinc salts to reduce risk of HIV infection
US5482053A (en) 1989-06-06 1996-01-09 Kelly; Patrick D. Condom lubricants containing zinc as an anti-viral agent
US5599551A (en) 1989-06-06 1997-02-04 Kelly; Patrick D. Genital lubricants containing zinc as an anti-viral agent
US6017521A (en) 1989-10-31 2000-01-25 Columbia Laboratories, Inc. Use of polycarboxylic acid polymers to treat vaginal infections
US5196452A (en) 1991-01-29 1993-03-23 Genelabs Incorporated Macrocyclic anti-viral compound and method
US5166173A (en) 1991-01-29 1992-11-24 Genelabs Incorporated Method of treating herpes simplex virus infection
US5312837A (en) 1991-01-29 1994-05-17 Genelabs Technologies, Inc. Method of treating viral infections with aryl macrocyclic compounds
US5244652A (en) * 1991-03-22 1993-09-14 E. B. Michaels Research Associates, Inc. Viscous surface active composition
IT1253711B (it) 1991-12-17 1995-08-23 Alfa Wassermann Spa Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali
US5308612A (en) 1992-08-12 1994-05-03 Blue Marble Research, Inc. Uses of polystyrenesulfonate and related compounds as inhibitors of transactivating transcription factor (TAT) and as therapeutics for HIV infection and AIDS
US5354558A (en) * 1992-09-10 1994-10-11 Mcneil-Pcc, Inc. Bioerodible contraceptive suppository
ZA942302B (en) * 1993-12-03 1995-09-29 Lafor Lab Ltd Viracidal bactericidal and spermicidal vaginal suppository
WO1996000543A1 (en) * 1994-06-29 1996-01-11 Moench Thomas R A device and method for acidic buffering
US5592949A (en) * 1994-06-29 1997-01-14 Moench; Thomas R. Device for acidic buffering and method for inactivation of pathogens
US5667492A (en) 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
FR2728464B1 (fr) * 1994-12-22 1997-04-30 Innothera Lab Sa Forme galenique unitaire, son procede d'obtention et ses utilisations
US6063773A (en) 1995-09-29 2000-05-16 Polydex Pharmaceuticals Ltd. Cellulose sulfate for use as antimicrobial and contraceptive agent
US6239182B1 (en) * 1995-10-13 2001-05-29 Rush-Presbyterian-St. Lukes Medical Center Method for preventing sexually transmitted diseases
US5925621A (en) 1995-10-13 1999-07-20 Rush-Presbyterian, St. Luke's Medical Center Method for preventing sexually transmitted diseases
US6028115A (en) 1995-10-13 2000-02-22 Rush-Presbyterian-St. Luke's Medical Center Method for preventing sexually transmitted diseases
US5932619A (en) 1995-10-13 1999-08-03 Rush-Presbyterian, St. Luke's Medical Center Method for preventing sexually transmitted diseases
US5741525A (en) 1995-10-24 1998-04-21 Marshall University Research Corporation Vaginal pharmaceutical hydrogen peroxide composition
BR9709228A (pt) * 1996-05-09 1999-08-10 Michel G Bergeron Método e formulações para prevenir e/ou tratar qualquer infecção (especificamente as dst incluindo hiv) inflamátoria neoplastica ou qualquer outro tipo de doenças das mucosas e/ou pele
US5700679A (en) 1996-06-07 1997-12-23 Novavax, Inc. Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity
WO1997047310A1 (fr) * 1996-06-12 1997-12-18 Stoa S.A. Compositions pharmaceutiques a base de gels de type glyceryl poly(meth)acrylate
RU2102977C1 (ru) * 1996-09-30 1998-01-27 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Суппозитории ректальные и вагинальные, обладающие антимикробным, антивирусным и противовоспалительным действием, и способ их получения
US5819742A (en) 1996-11-06 1998-10-13 Family Health International Vaginal device for preventing conception or the transmission of sexually transmitted diseases, or both
AU3903800A (en) * 1999-03-19 2000-10-09 Parker Hughes Institute Gel-microemulsion formulations

Also Published As

Publication number Publication date
BRPI0109078B8 (pt) 2021-05-25
HUP0301417A2 (hu) 2004-05-28
CA2402589C (en) 2011-02-01
EP1263411B1 (de) 2010-12-01
DE60143566D1 (de) 2011-01-13
PL202918B1 (pl) 2009-08-31
ES2357474T3 (es) 2011-04-26
BRPI0109078B1 (pt) 2017-03-14
WO2001066084A2 (en) 2001-09-13
IL151649A0 (en) 2003-04-10
BR0109078A (pt) 2003-12-30
CN100488517C (zh) 2009-05-20
AU2001243431B2 (en) 2006-05-25
RU2002126560A (ru) 2004-03-20
PL365461A1 (en) 2005-01-10
US6706276B2 (en) 2004-03-16
AU4343101A (en) 2001-09-17
US20040009223A1 (en) 2004-01-15
CN1431895A (zh) 2003-07-23
WO2001066084A3 (en) 2002-02-28
HU230315B1 (hu) 2016-01-28
EP1263411A2 (de) 2002-12-11
IL151649A (en) 2013-08-29
RU2274442C2 (ru) 2006-04-20
CA2402589A1 (en) 2001-09-13

Similar Documents

Publication Publication Date Title
ATE489937T1 (de) Zusammensetzungen und deren verwendung zum abfangen und inaktivieren pathogener mikroben und spermatozoen
Zeitlin et al. Tests of Buffergel for contraception and prevention of sexually transmitted diseases in animal models
Mercorio et al. The effect of a levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia
ATE455526T1 (de) Nicht-hormonales vaginales verhütungsmittel
EP1996209B1 (de) Kontrazeptive zusammensetzung
Barnhart et al. Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial
US7718642B2 (en) AIDS prophylactic lubricating composition
US20020151521A1 (en) Universal antiviral composition
Dayal et al. Disruption of the upper female reproductive tract epithelium by nonoxynol-9
Foote Effects of metronidazole, ipronidazole, and dibromochloropropane on rabbit and human sperm motility and fertility
WO2000015192A1 (en) Methods and materials related to bioadhesive contraceptive gels
Malcolm et al. Contraceptive efficacy of a novel intrauterine device (IUD) in white-tailed deer
Creatsas et al. Safety and tolerability of the new contraceptive sponge Protectaid®
WO2002045706A3 (en) The use of polymers for inactivating pathogens
Aitken et al. Bridging the gap between male and female fertility control; contraception-on-demand
US5725870A (en) Methods, composites and articles for contraception
US7144921B2 (en) Composition having antibacterial and antifungal properties
Rodriguez et al. Endometrial inflammatory response to insemination in jennies
US20070141177A1 (en) Method for enhancing fertility
Yang et al. Evaluation of clinical signs on equine coital exanthema in Thoroughbred horses
Buchweitz et al. Organ-preserving or ablative treatment?: which endoscopic procedure is sensible for treating tubo-ovarian abscesses?
DK1347753T5 (da) Topisk sammensætning og fremgangsmåde til behandling af urinstressinkontinens
Venere On research: new contraceptive gel prevents pregnancy and STDs
CN1370070A (zh) 作为局部用杀微生物杀精子剂的肉碱类似物
UA41022A (uk) Спосіб профілактики і лікування затримання навколоплідних оболонок (посліду) у корів

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties